AI Article Synopsis
- Heart failure (HF) involves complex processes like neurohormonal activation, inflammation, and oxidative stress, leading to heart damage and changes in structure.
- Researchers have identified several potential biomarkers for HF, with high-sensitivity troponins and soluble suppression of tumorigenesis-2 being the most promising for assessing risk, supplementing natriuretic peptides.
- Ongoing studies of additional biomarkers like galectin-3 and growth differentiation factor 15, along with multi-marker approaches and advanced technologies like genomics and proteomics, aim to improve HF management.
Article Abstract
Heart failure (HF) has a complex pathophysiology including neurohormonal activation, inflammation and oxidative stress that, together with comorbidities, promote progressive myocardial damage and cardiac remodeling. Over the years the study of these pathogenic mechanisms has led to the identification of several analytes potentially useful as biomarkers in HF. High-sensitivity troponins and soluble suppression of tumorigenesis-2 are the most promising biomarkers for risk stratification of HF, with independent value to natriuretic peptides. Other biomarkers currently being evaluated as predictors of adverse outcome in HF are galectin-3, growth differentiation factor 15, mid-regional pro-adrenomedullin as well as makers of renal dysfunction. The use of multi-marker scores as well as the application of genomics, transcriptomics, proteomics and metabolomics could further refine the management of HF.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1714/3592.35748 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!